Franklin Templeton Launches Inaugural Asian ETF Offerings Through ChinaAMC Partnership

Franklin Templeton partnered with China Asset Management to introduce two exchange-traded funds listed on the Hong Kong Stock Exchange, marking the asset manager's initial foray into Asia's ETF market. One fund balances Hong Kong and U.S. equities with a focus on cash-generating companies, while the second targets pharmaceutical firms across Hong Kong and developed markets. Both products offer trading in multiple currencies and exclude certain sectors to maintain thematic focus.

Franklin Templeton's entry into Asian ETFs represents a strategic shift toward leveraging regional partnerships rather than building standalone operations. By collaborating with ChinaAMC—a manager overseeing hundreds of billions in assets—the US firm gains immediate access to market infrastructure and expertise that would require years to develop independently. This approach signals how global asset managers are increasingly pursuing localized distribution networks to access mainland China investment opportunities while navigating regulatory complexities.

The two funds reflect distinct investor appetites: one targets stable, cash-generative businesses across Hong Kong and US markets, while the other concentrates on pharmaceutical innovation. Both deliberately exclude certain sectors to maintain thematic purity, and the multi-currency trading structure addresses practical friction points for cross-border investors managing holdings across different denominations.